1. France Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Klea Holding

Klea Holding

0.14
EUR
0.00
(0.00%)
66.26MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
74.29
69.73
26.79
19.1
8.81
4.94
0.71
0.75
0.05
0.05
0.05
0.06
0.07
- -
Basic EPS, GAAP
-17.19
-13.61
-17.91
-26.99
-11.08
-11.18
-1.68
-0.2
-0.03
-0.02
- -
- -
0.01
- -
Free Cash Flow per Basic Share
-17.78
-0.44
-22.48
-23.72
-13.84
-7.37
-1.59
-0.44
-0.05
-0.03
-0.01
- -
0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
34.73
23.26
29.66
14.38
10.67
0.2
-0.36
-0.17
0.1
0.08
0.08
0.09
0.09
0.09
Tangible Book Value per Share
1.1
-2.5
17.17
4.03
5.77
-2.57
-0.41
-0.19
-0.06
0.02
- -
0.01
0.01
0.01
Basic Weighted Avg Shares
- -
- -
- -
- -
1
2
14
25
138
264
294
307
308
307
Sales/Revenue/Turnover
11
13
11
9
10
9
10
19
7
14
14
17
22
- -
Operating Margin (%)
-16.97
-17.39
-73.48
-145.43
-125.22
-211.99
-213.43
-34.79
-51.26
-27.1
6.95
11.28
16.59
- -
Depreciation Expense
1
1
- -
1
1
1
4
-2
- -
3
3
- -
1
- -
Net Income, GAAP
-3
-3
-7
-13
-13
-20
-24
-5
-4
-5
1
1
2
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
17.8
20.18
- -
Profit Margin (%)
-23.14
-19.52
-66.86
-141.32
-125.79
-226.45
-234.96
-27.14
-62.14
-36.53
6.58
8.14
10.29
- -
Working Capital
2
4
8
5
6
-3
-3
-4
-8
1
2
5
5
5
LT Debt
2
1
- -
3
- -
- -
- -
- -
- -
5
8
6
5
5
Total Equity
5
4
12
8
13
- -
-5
-4
14
24
25
28
28
28
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.86
7.59
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
5.92
8.64
- -
Return on Common Equity (%)
-45.52
-53.71
-88.86
-133.19
-126.41
-303.88
- -
- -
- -
-27.52
3.73
5.4
8.21
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
2
2
- -
LT Borrowings
6
3
5
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
307
307
306
Market Capitalization
50
53
66

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
7
8
9
Cash, Cash Equivalents & STI
3
3
5
Accounts Receivable, Net
2
1
1
Inventories
- -
- -
- -
Total Current Liabilities
2
5
4
Payables & Accruals
- -
- -
- -
ST Debt
2
2
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-193.72%
-66.61%
-0.78%
Free Cash Flow
209.97%
405.72%
2,250.6%
Net Income, GAAP
8.16%
1.19%
62.35%
Sales/Revenue/Turnover
17.18%
17.68%
28.42%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
14
2024
- -
- -
17
2025
- -
- -
22

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
0.01

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Raphael Smila
Full Time Employees
124
Sector
Health technology
Industry
Medical specialties
Address
34 rue Laffitte Paris IDF France 75009
IPO Date
Jul 5, 2011
Website
visiomed.fr
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Klea Holding SA Klea Holding SA (ALKLH.PA) serves as a France-based international holding company that acquires, develops, and digitalizes businesses across multiple sectors to maximize growth and value, with a primary emphasis on healthcare technologies and services. Founded in 2007 and headquartered at 74 rue Blanche in Paris, the company operates through key subsidiaries including Smart Salem, which runs digitalized medical fitness testing centers in the United Arab Emirates accredited by the Dubai Health Authority (DHA) and offering rapid results within 30 minutes for residency visas, work permits, and preventive health check-ups; Smart Health, a joint venture established in September 2023 with Abrar Communications and Al-Ghazzawi to deliver innovative diagnostic solutions in Saudi Arabia; and Bewellthy, created in 2022 as a provider of connected health and teleconsultation platforms featuring medical devices, software, tele-expertise, remote monitoring, tele-assistance, and health concierge services deployed in France, Italy, and the United States. The group targets government agencies, healthcare providers, and individual consumers in the Middle East and Europe, spanning connected health, digitalized medical centers, and other medical products segments. In recent developments, Klea Holding, formerly known as Visiomed Group SA, changed its name in June 2024 and significantly improved half-year results in 2025 through restructuring that reduced central costs, terminated office leases and service contracts, and simplified operations at Smart Salem, while confirming normalized EBITDA of €3.9 million and targeting consolidated EBITDA well above €3.3 million for full-year 2025; it signed a key partnership with Mobadara Investment for Smart Health to resume construction of Riyadh's first digital medical center in Q4 2025 for a 2026 opening, shifted Smart Health consolidation to the equity method post-transaction, repurchased 20,000,652 PARK warrants for €0.5 million to eliminate dilution, launched a share buyback program, adopted a new governance structure with Raphael Smila as Chairman and CEO following the June 2025 Annual General Meeting, and accelerated Smart Salem growth with +55% test volume increase in early 2025.